NCT03819153), secondary analyses of GLP-1RA CVOTs indicate that liraglutide [17], semaglutide [18], dulaglutide [25] and efpeglenatide [20] may reduce the relative risk of a composite kidney outcome, comprising new-onset macroalbuminuria, worsening kidney function, end-stage renal disease and renal death, by 1536%
Wound Repair and Regeneration, 2(4), 259-269
Overall pipeline momentum is unprecedented for metabolic disease
Alm disso, ela estimula que o indivduo se sinta bem e com mais energia, aumentando o gasto calrico atravs da melhora na performance
8 Even if you can afford treatment, getting the drugs is another story
You can get beta-alanine from foods that contain carnosine or through supplements